Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Alfieri

Showing results (31-40 of 91) with videos related to

Pageof 10
Sort By:
Journal of Cardiovascular Echography|March 15, 2024
Catch the Cath or Not? A Hamletic Dilemma after 10 YearsFrancesco Natale, Giuseppe Raucci, Riccardo Molinari, et al.
Cancer Research|August 4, 2018
A Polysome-Based microRNA Screen Identifies miR-24-3p as a Novel Promigratory miRNA in MesotheliomaStefania Oliveto, Roberta Alfieri, Annarita Miluzio, et al.
Cell Metabolism|September 11, 2018
The Translational Machinery of Human CD4<sup>+</sup> T Cells Is Poised for Activation and Controls the Switch from Quiescence to Metabolic RemodelingSara Ricciardi, Nicola Manfrini, Roberta Alfieri, et al.
Oncogene|September 14, 2004
Dose-dependent effect of FHIT-inducible expression in Calu-1 lung cancer cell lineAndrea Cavazzoni, Pier Giorgio Petronini, Maricla Galetti, et al.
Cells|November 28, 2019
Gene Expression Profiles Controlled by the Alternative Splicing Factor Nova2 in Endothelial CellsElisa Belloni, Anna Di Matteo, Davide Pradella, et al.
Cell Metabolism|December 6, 2018
The Translational Machinery of Human CD4<sup>+</sup> T Cells Is Poised for Activation and Controls the Switch from Quiescence to Metabolic RemodelingSara Ricciardi, Nicola Manfrini, Roberta Alfieri, et al.
Developmental Biology|July 9, 2019
Modulating eIF6 levels unveils the role of translation in ecdysone biosynthesis during Drosophila developmentArianna Russo, Guido Gatti, Roberta Alfieri, et al.
Scientific Reports|September 12, 2019
Pre-treatment with the CDK4/6 inhibitor palbociclib improves the efficacy of paclitaxel in TNBC cellsDaniele Cretella, Claudia Fumarola, Mara Bonelli, et al.
Frontiers in Oncology|May 13, 2021
Small Cell Lung Cancer Transformation as a Resistance Mechanism to Osimertinib in Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: Case Report and Literature ReviewAlessandro Leonetti, Roberta Minari, Giulia Mazzaschi, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 29, 2018
The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cellsDaniele Cretella, Andrea Ravelli, Claudia Fumarola, et al.
Pageof 10

Showing results (31-40 of 91) with videos related to

Sort By:
Pageof 10
Journal of Cardiovascular Echography|March 15, 2024
Catch the Cath or Not? A Hamletic Dilemma after 10 YearsFrancesco Natale, Giuseppe Raucci, Riccardo Molinari, et al.
Cancer Research|August 4, 2018
A Polysome-Based microRNA Screen Identifies miR-24-3p as a Novel Promigratory miRNA in MesotheliomaStefania Oliveto, Roberta Alfieri, Annarita Miluzio, et al.
Cell Metabolism|September 11, 2018
The Translational Machinery of Human CD4<sup>+</sup> T Cells Is Poised for Activation and Controls the Switch from Quiescence to Metabolic RemodelingSara Ricciardi, Nicola Manfrini, Roberta Alfieri, et al.
Oncogene|September 14, 2004
Dose-dependent effect of FHIT-inducible expression in Calu-1 lung cancer cell lineAndrea Cavazzoni, Pier Giorgio Petronini, Maricla Galetti, et al.
Cells|November 28, 2019
Gene Expression Profiles Controlled by the Alternative Splicing Factor Nova2 in Endothelial CellsElisa Belloni, Anna Di Matteo, Davide Pradella, et al.
Cell Metabolism|December 6, 2018
The Translational Machinery of Human CD4<sup>+</sup> T Cells Is Poised for Activation and Controls the Switch from Quiescence to Metabolic RemodelingSara Ricciardi, Nicola Manfrini, Roberta Alfieri, et al.
Developmental Biology|July 9, 2019
Modulating eIF6 levels unveils the role of translation in ecdysone biosynthesis during Drosophila developmentArianna Russo, Guido Gatti, Roberta Alfieri, et al.
Scientific Reports|September 12, 2019
Pre-treatment with the CDK4/6 inhibitor palbociclib improves the efficacy of paclitaxel in TNBC cellsDaniele Cretella, Claudia Fumarola, Mara Bonelli, et al.
Frontiers in Oncology|May 13, 2021
Small Cell Lung Cancer Transformation as a Resistance Mechanism to Osimertinib in Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: Case Report and Literature ReviewAlessandro Leonetti, Roberta Minari, Giulia Mazzaschi, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 29, 2018
The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cellsDaniele Cretella, Andrea Ravelli, Claudia Fumarola, et al.
Pageof 10